首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs
【24h】

GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs

机译:GPR37与多巴胺转运蛋白结合,调节多巴胺的摄取和对多巴胺能药物的行为反应

获取原文
获取原文并翻译 | 示例
           

摘要

The orphan G protein-coupled receptor 37 (GPR37) is a substrate of parkin; its insoluble aggregates accumulate in brain samples of Parkinson's disease patients. We report here that GPR37 interacts with the dopamine transporter (DAT) and modulates DAT activity. GPR37 and DAT were found colocalized in mouse striatal presyn-aptic membranes and in transfected cells and their interaction was confirmed by coimmunoprecipitation assays. Gpr37-null mutant mice showed enhanced DAT-mediated dopamine uptake in striatal membrane samples, with a significant increase in the number of plasma membrane DAT molecules. The null mutant mice also exhibited a decrease in cocaine-induced locomotor activity and in catalepsy induced by dopamine receptor antagonists. These results reveal the specific role of GPR37, a putative peptidergic G protein-coupled receptor, in modulating the functional expression of DAT and the behavioral responses to dopaminergic drugs.
机译:孤儿G蛋白偶联受体37(GPR37)是Parkin的底物。帕金森氏病患者的大脑样本中积累了不溶性聚集物。我们在这里报告GPR37与多巴胺转运蛋白(DAT)相互作用并调节DAT活性。 GPR37和DAT被发现共定位在小鼠纹状体突触前膜和转染的细胞中,并通过共免疫沉淀试验证实了它们的相互作用。 Gpr37空突变小鼠在纹状体膜样品中显示出DAT介导的多巴胺摄取增强,质膜DAT分子数量显着增加。空突变小鼠还表现出可卡因诱导的运动活性和多巴胺受体拮抗剂诱导的僵直症的减少。这些结果揭示了GPR37,一种假定的肽能G蛋白偶联受体,在调节DAT的功能性表达和对多巴胺能药物的行为反应中的特定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号